BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31056344)

  • 1. Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa.
    Josephs KA; Murray ME; Tosakulwong N; Weigand SD; Knopman DS; Petersen RC; Jack CR; Whitwell JL; Dickson DW
    Alzheimers Dement; 2019 Jun; 15(6):799-806. PubMed ID: 31056344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein contributions to brain atrophy acceleration in Alzheimer's disease and primary age-related tauopathy.
    Josephs KA; Martin PR; Weigand SD; Tosakulwong N; Buciuc M; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Dickson DW; Jack CR; Whitwell JL
    Brain; 2020 Dec; 143(11):3463-3476. PubMed ID: 33150361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
    Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
    Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).
    Josephs KA; Murray ME; Tosakulwong N; Whitwell JL; Knopman DS; Machulda MM; Weigand SD; Boeve BF; Kantarci K; Petrucelli L; Lowe VJ; Jack CR; Petersen RC; Parisi JE; Dickson DW
    Acta Neuropathol; 2017 May; 133(5):705-715. PubMed ID: 28160067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 Is Associated with Subiculum and Cornu Ammonis 1 Hippocampal Subfield Atrophy in Primary Age-Related Tauopathy.
    Youssef H; Gatto RG; Pham NTT; Petersen RC; Machulda MM; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
    J Alzheimers Dis; 2024; 99(3):1023-1032. PubMed ID: 38728190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.
    Buciuc M; Wennberg AM; Weigand SD; Murray ME; Senjem ML; Spychalla AJ; Boeve BF; Knopman DS; Jack CR; Kantarci K; Parisi JE; Dickson DW; Petersen RC; Whitwell JL; Josephs KA
    J Alzheimers Dis; 2020; 73(4):1511-1523. PubMed ID: 31929165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.
    de Flores R; Wisse LEM; Das SR; Xie L; McMillan CT; Trojanowski JQ; Robinson JL; Grossman M; Lee E; Irwin DJ; Yushkevich PA; Wolk DA
    Alzheimers Dement; 2020 Jun; 16(6):843-852. PubMed ID: 32323446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
    Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
    J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging brain atrophy assessment in primary age-related tauopathy (PART).
    Quintas-Neves M; Teylan MA; Besser L; Soares-Fernandes J; Mock CN; Kukull WA; Crary JF; Oliveira TG
    Acta Neuropathol Commun; 2019 Dec; 7(1):204. PubMed ID: 31818331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
    Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 is a key player in the clinical features associated with Alzheimer's disease.
    Josephs KA; Whitwell JL; Weigand SD; Murray ME; Tosakulwong N; Liesinger AM; Petrucelli L; Senjem ML; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Jack CR; Parisi JE; Petersen RC; Dickson DW
    Acta Neuropathol; 2014; 127(6):811-24. PubMed ID: 24659241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy.
    Zhang X; Sun B; Wang X; Lu H; Shao F; Rozemuller AJM; Liang H; Liu C; Chen J; Huang M; Zhu K
    Neurosci Bull; 2019 Apr; 35(2):183-192. PubMed ID: 30382507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
    Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
    J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies.
    Hanko V; Apple AC; Alpert KI; Warren KN; Schneider JA; Arfanakis K; Bennett DA; Wang L
    Neurobiol Aging; 2019 Feb; 74():171-181. PubMed ID: 30453234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features.
    Josephs KA; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Liesinger AM; Petrucelli L; Senjem ML; Ivnik RJ; Parisi JE; Petersen RC; Dickson DW
    Ann Neurol; 2015 Nov; 78(5):697-709. PubMed ID: 26224156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hippocampal longitudinal axis-relevance for underlying tau and TDP-43 pathology.
    Lladó A; Tort-Merino A; Sánchez-Valle R; Falgàs N; Balasa M; Bosch B; Castellví M; Olives J; Antonell A; Hornberger M
    Neurobiol Aging; 2018 Oct; 70():1-9. PubMed ID: 29935415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed tau and TDP-43 pathology in a patient with unclassifiable primary progressive aphasia.
    Flanagan EP; Duffy JR; Whitwell JL; Vemuri P; Dickson DW; Josephs KA
    Neurocase; 2016; 22(1):55-9. PubMed ID: 25929342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TDP-43 and tau concurrence in the entorhinal subfields in primary age-related tauopathy and preclinical Alzheimer's disease.
    Llamas-Rodríguez J; Oltmer J; Marshall M; Champion S; Frosch MP; Augustinack JC
    Brain Pathol; 2023 Jul; 33(4):e13159. PubMed ID: 37037195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of casein kinase 1ε associated with TDP-43 and tau pathologies in Alzheimer's disease.
    Gu J; Hu W; Tan X; Qu S; Chu D; Gong CX; Iqbal K; Liu F
    Brain Pathol; 2020 Mar; 30(2):283-297. PubMed ID: 31376192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.